Taltz (ixekizumab) for the Treatment of Non-Radiographic Axial Spondyloarthritis

Taltz® (ixekizumab) is the first and the only IL-17A antagonist therapy for the treatment of active non-radiographic axial spondyloarthritis (nr-axSpA). Credit: Eli Lilly.



  • Taltz
  • Taltz
  • Taltz